Expiratory randomized phase II trial for optimizing treatment dose and duration of adjuvant S-1 plus oxaliplatin in patients with stage III colon cancer
Latest Information Update: 24 Aug 2021
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms SOAP trial
- 24 Aug 2021 New trial record
- 03 Jul 2021 Primary endpoint has not been met (3-year disease free survival (3-months and 6-months)) , according to Results presented at the 23rd World Congress on Gastrointestinal Cancer
- 03 Jul 2021 Results presented at the 23rd World Congress on Gastrointestinal Cancer